Krska Z, Sváb J
I. Chirurgická klinika 1. LF UK a VFN v Praze.
Rozhl Chir. 2009 Oct;88(10):563-7.
Fulminant acute (FAP) and subfulminant pancreatitis (SFAP) represent the latterly defined subgroup within the severe acute pancreatitis (SAP) with rapidly progressing organ failure (OF) and multi-organ failure MOF high level of lethality and poor effect of both conservative and surgical treatment.
Analysis of indigenous set of patients diagnosed with SAP, particularly with FAP and SFAP, and comparison of data with the literature. Retrospectively prospective study of data collected over the period 2003 to 2007.
Mild form of AP (MAP) 128 p., etiology %: biliary/alcohol/other - 52/36/12; SAP 106 p., etiology %: biliary/alcohol/other - 51/41/9; ESAP 21 p. i.e. 20% of SAP, aetiology %: biliary/alcohol/other - 3/27/39. Age: MAP/SAP/ESAP - 43.2/45.8/46.1. Lethality %: MAP/SAP/ESAP: 0/19/71.5% (i.e. 78.5% of all deaths of TAP. ESAP 21 p., FAP 6 p., SFAP 15 p. FAP/SFAP: M/F 3/3 or 11/4, age 44.5 (17-81) or 46.8 (25-73). FAP etiology: 1x biliary, 1x alcohol, 4x?; SFAP: 6x biliary, 5x alcohol, 4x?. FAP: 4x severe hypercholesterolemia or hypertriglyceridemia, SFAP dtto 3x. FAP lethality: 83%, SFAP: 67%. Mean survival rate: FAP 4.1 d., SAP 9.2 d. FAP treatment: conservative 3 p., surgical 3 p., hemoelimination 2 p. SFAP treatment: conservative 9 p., surgical 6 p (reoperated 92% of all surgically treated, 7x on average), hemoelimination 8 p.
Mortality prediction especially in FAP and SAP--progression and early occurrence of organ failure and its dynamics, existence of organ failure at the time of patient's admission and its rapid deterioration. Action of age, comorbidity and aetiology: insufficient data for meta-analysis; difference between ESAP and LAP has no statistic importance. Indigenous set of patients proves incidence, progression and lethality in FAP and SFAP, demonstrates higher incidence of hyperlididemia and hypercholesterolemia in FAP (60%) compared to SFAP with far more frequent biliary or alcohol aetiology. Among FAP, SAP and LSAP no age-dependent differences were proved. Absolute dominance of organ failure symptoms, suspicion to infected necrosis rather rarely expressed. Differences in prognosis in relation to applied treatment--either conservative or surgical (FAP surgery 50%, SFAP surgery 60%) were not observed. In section severe destructive findings in pancreas and its vicinity as well as extensive organ lesions were observed.
Our own results are in concord with the results of other studies. It appears pretty useful to search for further ESAP predicting factors within meta-analytical studies. Intensive resuscitation care since the admission is a necessity, despite that, particularly in FAP, the results are unfavourable; surgical treatment has higher impact in SFAP than in AP, where often is ultimum refugium only.
暴发性急性胰腺炎(FAP)和亚暴发性胰腺炎(SFAP)是严重急性胰腺炎(SAP)中最新定义的亚组,伴有快速进展的器官衰竭(OF)和多器官功能衰竭(MOF),致死率高,保守治疗和手术治疗效果均不佳。
分析诊断为SAP的本地患者群体,特别是FAP和SFAP患者,并将数据与文献进行比较。对2003年至2007年期间收集的数据进行回顾性前瞻性研究。
轻症急性胰腺炎(MAP)128例,病因百分比:胆源性/酒精性/其他 - 52/36/12;SAP 106例,病因百分比:胆源性/酒精性/其他 - 51/41/9;极重症急性胰腺炎(ESAP)21例,即占SAP的20%,病因百分比:胆源性/酒精性/其他 - 3/27/39。年龄:MAP/SAP/ESAP - 43.2/45.8/46.1。致死率百分比:MAP/SAP/ESAP:0/19/71.5%(即占所有急性胰腺炎死亡病例的78.5%)。ESAP 21例,FAP 6例,SFAP 15例。FAP/SFAP:男/女为3/3或11/4,年龄44.5(17 - 81)或46.8(25 - 73)。FAP病因:1例胆源性,1例酒精性,4例不明;SFAP:6例胆源性,5例酒精性,4例不明。FAP:4例伴有严重高胆固醇血症或高甘油三酯血症,SFAP有3例。FAP致死率:83%,SFAP:67%。平均生存率:FAP 4.1天,SAP 9.2天。FAP治疗:保守治疗3例,手术治疗3例,血液滤过2例。SFAP治疗:保守治疗9例,手术治疗6例(所有接受手术治疗的患者中92%进行了再次手术,平均7次),血液滤过8例。
死亡率预测,尤其是在FAP和SAP中——器官衰竭的进展和早期发生及其动态变化、患者入院时器官衰竭的存在及其快速恶化。年龄、合并症和病因的作用:缺乏进行荟萃分析的数据;ESAP和轻症急性胰腺炎(LAP)之间的差异无统计学意义。本地患者群体证实了FAP和SFAP的发病率、进展和致死率,表明FAP(60%)中高脂血症和高胆固醇血症的发病率高于SFAP,且胆源性或酒精性病因更为常见。在FAP、SAP和轻症重症急性胰腺炎(LSAP)之间未证实存在年龄依赖性差异。器官衰竭症状绝对占主导地位,怀疑感染性坏死的情况很少出现。未观察到与所应用治疗(保守治疗或手术治疗)相关的预后差异(FAP手术治疗占50%,SFAP手术治疗占60%)。在胰腺及其周围区域观察到严重的破坏性病变以及广泛的器官损伤。
我们自己的结果与其他研究结果一致。在荟萃分析研究中寻找更多ESAP预测因素似乎非常有用。自入院起进行强化复苏治疗是必要的,尽管如此,特别是在FAP中,结果并不理想;手术治疗在SFAP中的影响比在急性胰腺炎中更大,在急性胰腺炎中手术往往只是最后的手段。